PQQ was found to alleviate mitochondrial dysfunction, reduce ROS production and inhibit the activation of the NF‐κB/pyroptosis pathway, leading to a potential therapeutic intervention for diabetic nephropathy and hyperglycemia‐induced renal fibrosis.15 Here, NFKB1 is linked to diabetic kidney disease.